References
Drake MJ, Nixon PM, Crew JP. Drug-induced bladder and urinary disorders: incidence, prevention and management. Drug Saf 1998 Jul; 19 (1): 45–55
Marshall HJ, Beevers DG. Alpha-adrenergic blockade and urinary incontinence. J Hypertens 1993; 11: 1152–3
Nakano M, Ishihara S, Deguchi T, et al. Fluoroquinolone associated bladder stone. J Urol 1997; 157: 946
Stallard S, Prescott S. Postoperative urinary retention in general surgical patients. Br J Surg 1988; 75: 1141–3
Petersen TK, Husted SE, Rybro L. Urinary retention during i.m. and extradural morphine analgesia. Br J Anaesth 1982; 54: 1175–8
Cox PJ. Cyclophosphamide cystitis: identification of acrolein as the causative agent. Biochem Pharmacol 1979; 28: 2045–9
Levine LA, Richie JP. Urological complications of cyclophosphamide [letter]. J Urol 1989; 141: 1063–9
O’Neill GFA. Tiaprofenic acid as a cause of non-bacterial cystitis. Med J Aust 1994; 160: 123–5
Fairchild WV, Spence CR, Soloman HD, et al. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979; 122: 163–4
Millard RJ, McCredie S. Bladder cancer in patients on low-dose methotrexate and corticosteroids [letter]. Lancet 1994; 343: 1222–3
Rights and permissions
About this article
Cite this article
Bladder and Urinary Tract Prone to Drug-Induced Disorders. Drugs Ther. Perspect 13, 12–16 (1999). https://doi.org/10.2165/00042310-199913070-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199913070-00005